Mycobacterium avium intracellulare.
Keywords:
MAC, AIDS, mycobacteriasAbstract
Mycobacterium avium intracellulare (MAC) is one of the mycobacterias most frequently found in patients with HIV infection, but their frequency is decreasing and has been associated to active antiretroviral therapy (HAART) and prophylactic antibiotic use. Skin involvement is very rare but has been described as papules, ulcers and verrucous plaques. A case is reported in a inmunossupressed patient with a unique skin lesion by Mycobacterium avium intracellulare.
Author Biographies
Mónica Viviana Patiño
Médica Interna, Universidad Pontificia Bolivariana, Medellín.
Mónica Alejandra Gaviria
Dermatóloga, Dermatóloga Universidad Pontificia Bolivariana Programa ITS/ VIH-sida, Medellín
Luz Marina Peláez
Médica del Programa ITS / VIH-sida, Medellín
References
1. Morales JJ. Infección po micobacterias no tuberculosas en pacientes infectados por el virus de la inmunodeficiencia humana. Bol Med Hosp Infant Mex. 2006; 192-9.
2. Rigsby MO, Curtis AM. Pulmonary disease from non tuberculous mycobacteria in patients with human immunodeficiency virus. Chest. 1994; 106: 913-9
3. Hidalgo C, León L, Pasquau J. Infección diseminada por Mycobacterium avium complex en pacientes inmunocompetentes. Enf. Infecc Microbiol Clin. 2000; 18: 365-6.
4. Collins FM. Mycobacterial disease, immunosuppression and acquired immunodeficiency syndrome. Clin Microbiol Rev. 1989; 2: 360-77.
5. Inderlied CB, Kemper CA, Bermudez LE. The mycobacterium avium complex. Clin Microbiol Rev. 1993; 6: 266-310.
6. Rossman MD. Colonization with Mycobacterium avium complex – an outdated concept. Eur Respir J. 1999; 13: 479
7. Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, et al. Activity of Moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob Agents Chemother. 2001; 1: 217–22.
2. Rigsby MO, Curtis AM. Pulmonary disease from non tuberculous mycobacteria in patients with human immunodeficiency virus. Chest. 1994; 106: 913-9
3. Hidalgo C, León L, Pasquau J. Infección diseminada por Mycobacterium avium complex en pacientes inmunocompetentes. Enf. Infecc Microbiol Clin. 2000; 18: 365-6.
4. Collins FM. Mycobacterial disease, immunosuppression and acquired immunodeficiency syndrome. Clin Microbiol Rev. 1989; 2: 360-77.
5. Inderlied CB, Kemper CA, Bermudez LE. The mycobacterium avium complex. Clin Microbiol Rev. 1993; 6: 266-310.
6. Rossman MD. Colonization with Mycobacterium avium complex – an outdated concept. Eur Respir J. 1999; 13: 479
7. Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, et al. Activity of Moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob Agents Chemother. 2001; 1: 217–22.
How to Cite
1.
Patiño MV, Gaviria MA, Peláez LM. Mycobacterium avium intracellulare. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 6 [cited 2024 Jul. 3];16(3):211-3. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/117
Downloads
Download data is not yet available.
Downloads
Published
2019-02-06
How to Cite
1.
Patiño MV, Gaviria MA, Peláez LM. Mycobacterium avium intracellulare. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 6 [cited 2024 Jul. 3];16(3):211-3. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/117
Issue
Section
Case Report
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
